Alterity Therapeutics Limited (PBN.F)
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease.
0.31+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+4.7%
The outlook
Alterity Therapeutics Limited currently reads as leaning bullish based on above its 50- & 200-day averages, 53% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Market cap
$68.3M
52-wk high
0.50
52-wk low
0.10
50-day avg
0.31
200-day avg
0.25
Trailing P/E
—